[1]
2025. EVALUATION OF THE EFFECT OF METFORMIN ON SERUM INFLAMMATORY BIOMARKERS (CRP, IL-6) IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. The Research of Medical Science Review. 3, 5 (May 2025), 982–987.